基于CD44受体驱动的氧化石墨烯基纳米载体用于癌症治疗
Ludmila Žárská1, Michaela Gapčová2, Zuzana Chaloupková1
1Regional Centre of Advanced Technologies and Materials, Czech Advanced Technology and Research Institute (CATRIN), Palacký University Olomouc, Slechtitelu 26, Olomouc 779 00, Czech Republic.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
|January 28, 2026
概括
氨酸 (HA) 功能化石墨烯氧化物 (GO) 纳米载体通过与CD44受体相互作用来增强向药物递送. 这提高了CD44表达细胞的抗癌疗效,证明了精确癌症治疗的潜力.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术纳米技术
- 癌症生物学 癌症生物学
背景情况:
- 氨酸 (HA) 和CD44受体相互作用对于瘤细胞的识别和药物吸收至关重要.
- 石墨烯氧化物 (GO) 纳米平台为向药物输送提供了潜力.
研究的目的:
- 为了研究HA的功能化和度如何影响GO纳米载体的生物行为,用于多克索鲁比 (DOX) 输送.
- 为了比较不同CD44表达水平的细胞系中HA功能化的GO纳米载体的疗效.
主要方法:
- 在不同度下通过PEGylation和HA结合制备GO纳米平台.
- 在纳米载体上加载多克索鲁比 (DOX).
- 使用光谱和显微分析进行表征.
- 在CD44+和CD44−细胞系中评估细胞吸收,细胞毒性和抗癌活性.
主要成果:
- HA功能化增强了CD44介导的细胞吸收,并增加了CD44+HT-1080细胞中的抗癌活性.
- 只有GO@PEG载体表现出最小的细胞毒性,表明良好的生物相容性.
- CD44-SKBR3细胞的吸收有限,活力更高,与CD44表达率较低相关.
- 同焦显微镜和拉曼光谱学证实了纳米载体的细胞内积累和周核定位.
结论:
- 在改善基于GO的纳米平台的特异性,细胞吸收和安全性方面,HA发挥着重要作用.
- CD44受体水平极大地影响了向纳米载体的治疗效率.
- 该研究支持开发针对受体的生物相容纳米载体系统,用于精确的癌症治疗.
相关概念视频
Cancer Therapies
10.2K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.2K
Targeted Cancer Therapies
8.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.9K
Oxidation Numbers
42.5K
In redox reactions, the transfer of electrons occurs between reacting species. Electron transfer is described by a hypothetical number called the oxidation number (or oxidation state). It represents the effective charge of an atom or element, which is assigned using a set of rules.
42.5K
Pyruvate Oxidation
168.8K
After glycolysis, the charged pyruvate molecules enter the mitochondria via active transport and undergo three enzymatic reactions. These reactions ensure that pyruvate can enter the next metabolic pathway so that energy stored in the pyruvate molecules can be harnessed by the cells.
First, the enzyme pyruvate dehydrogenase removes the carboxyl group from pyruvate and releases it as carbon dioxide. The stripped molecule is then oxidized and releases electrons, which are then picked up by NAD+...
First, the enzyme pyruvate dehydrogenase removes the carboxyl group from pyruvate and releases it as carbon dioxide. The stripped molecule is then oxidized and releases electrons, which are then picked up by NAD+...
168.8K
Oxidation-Reduction Reactions
75.6K
Oxidation–Reduction Reactions
75.6K
Internal Receptors
74.6K
Many cellular signals are hydrophilic and therefore cannot pass through the plasma membrane. However, small or hydrophobic signaling molecules can cross the hydrophobic core of the plasma membrane and bind to internal, or intracellular, receptors that reside within the cell. Many mammalian steroid hormones use this mechanism of cell signaling, as does nitric oxide (NO) gas.
74.6K


